As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Shtanko, Olena
The objective of this proposal is to interrogate the interaction(s) between EBOV and macrophage podosomes, mechanosensitive adhesive structures used by macrophages to migrate through tissues and sample antigens.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Hammargren, Mark
Acquisition and deployment of the CrimeEye video surveillance system with Genetec video analytics that will allow our security team to maximize their efforts to keep our campus secure by having better situational awareness through enhanced monitoring, verification and validation of threats improving security response times.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Ross, Corinna
Funded by
National Institutes of Health
As the human population shifts to a higher proportion of aged and geriatric individuals, it is critical that we develop appropriate animal models in which to test interventional methods to maintain human health and to systemically treat age-related disease. Marmosets offer a unique model in which to evaluate the translational gap between cellular aging and clinical application.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Ross, Corinna
We have previously found that geriatric marmosets have a significantly reduced microbial diversity, and we have also found in pilot testing that oral fecal transplant can be safely used to alter a young animal?s microbial community. We hypothesize that loss of microbial diversity is significantly associated with the aging process, and that oral FMT may be a potential therapeutic for healthspan maintenance. Specific Aim 1: Determine if changes in the gut microbiome with aging are associated with significant changes in measures of healthspan and lifespan.
